Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Tourette’s syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually. This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers. By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development. Presents the first comprehensive, tabulated summary of literature on the epidemiological data on smoking and neurological disease Includes preclinical and clinical data on nicotine in neurological diseases and mechanisms of action of nicotine in neuroprotection Features a comprehensive summary of non-nicotine smoke constituents with potentially neuroprotective and anti-inflammatory properties Discusses Multiple Sclerosis, Alzheimer’s disease, Parkinson’s Disease, Schizophrenia, Depression, ADHD, Anxiety and Tourette’s Syndrome in the context of smoking and nicotine

Produk Detail:

  • Author : Emilija Veljkovic
  • Publisher : Academic Press
  • Pages : 164 pages
  • ISBN : 0128129239
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKNicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases
  • Author : Emilija Veljkovic,Wenhao Xia,Blaine Phillips,Ee Tsin Wong,Jenny Ho,Alberto Oviedo Casado,Julia Hoeng,Manuel Peitsch
  • Publisher : Academic Press
  • Release : 15 January 2018
GET THIS BOOKNicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Tourette’s syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases
  • Author : Emilija Veljkovic,Wenhao Xia,Blaine Phillips,Jenny Ho,Ee Tsin Wong,Alberto Oviedo Casado,Julia Hoeng,Manuel Peitsch
  • Publisher : Academic Press
  • Release : 03 January 2018
GET THIS BOOKNicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Tourette's syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may

Neuroscience of Nicotine

Neuroscience of Nicotine
  • Author : Victor R. Preedy
  • Publisher : Academic Press
  • Release : 20 March 2019
GET THIS BOOKNeuroscience of Nicotine

Neuroscience of Nicotine: Mechanisms and Treatment presents the fundamental information necessary for a thorough understanding of the neurobiological underpinnings of nicotine addiction and its effects on the brain. Offering thorough coverage of all aspects of nicotine research, treatment, policy and prevention, and containing contributions from internationally recognized experts, the book provides students, early-career researchers, and investigators at all levels with a fundamental introduction to all aspects of nicotine misuse. With an estimated one billion individuals worldwide classified as tobacco users—

Toxicological Evaluation of Electronic Nicotine Delivery Products

Toxicological Evaluation of Electronic Nicotine Delivery Products
  • Author : Manuel C. Peitsch,Julia Hoeng
  • Publisher : Academic Press
  • Release : 14 January 2021
GET THIS BOOKToxicological Evaluation of Electronic Nicotine Delivery Products

Toxicological Evaluation of Electronic Nicotine Delivery Products (ENDP) discusses the scientific basis for the toxicological assessment and evaluation of ENDPs. The book covers aerosol chemistry, in vitro and in vivo studies as well as clinical studies. It provides the basis for the evaluation of short and long term-effects, along with relative risks. It also examines the potential role of ENDPs in tobacco harm reduction and how they may reduce the risk of disease in smokers who switch to them. This

Addictive Substances and Neurological Disease

Addictive Substances and Neurological Disease
  • Author : Ronald Ross Watson,Sherma Zibadi
  • Publisher : Academic Press
  • Release : 18 February 2017
GET THIS BOOKAddictive Substances and Neurological Disease

Addictive Substances and Neurological Disease: Alcohol, Tobacco, Caffeine, and Drugs of Abuse in Everyday Lifestyles is a complete guide to the manifold effects of addictive substances on the brain, providing readers with the latest developing research on how these substances are implicated in neurological development and dysfunction. Cannabis, cocaine, and other illicit drugs can have substantial negative effects on the structure and functioning of the brain. However, other common habituating and addictive substances often used as part of an individual’

Brain Protection in Schizophrenia, Mood and Cognitive Disorders

Brain Protection in Schizophrenia, Mood and Cognitive Disorders
  • Author : Michael S. Ritsner
  • Publisher : Springer Science & Business Media
  • Release : 16 June 2010
GET THIS BOOKBrain Protection in Schizophrenia, Mood and Cognitive Disorders

Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to

Pituitary Adenylate Cyclase-Activating Polypeptide

Pituitary Adenylate Cyclase-Activating Polypeptide
  • Author : Hubert Vaudry,Akira Arimura
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOKPituitary Adenylate Cyclase-Activating Polypeptide

Pituitary Adenylate Cyclase-Activating Polypeptide is the first volume to be written on the neuropeptide PACAP. It covers all domains of PACAP from molecular and cellular aspects to physiological activities and promises for new therapeutic strategies. Pituitary Adenylate Cyclase-Activating Polypeptide is the twentieth volume published in the Endocrine Updates book series under the Series Editorship of Shlomo Melmed, MD.

Drug Information for Mental Health 2001

Drug Information for Mental Health 2001
  • Author : Matthew A. Fuller,Martha Sajatovic
  • Publisher : Lexi-Comp Incorporated
  • Release : 24 June 2021
GET THIS BOOKDrug Information for Mental Health 2001

A full drug reference with mental health specific information, this text presents 1360 drug monographs and 33 herbal monographs, cross-referenced by page number from brand name to generic name. The effects on mental status and psychiatric treatment are also discussed.

Encyclopedia of Psychopharmacology

Encyclopedia of Psychopharmacology
  • Author : Ian Stolerman
  • Publisher : Springer Science & Business Media
  • Release : 31 July 2010
GET THIS BOOKEncyclopedia of Psychopharmacology

Here is a broad overview of the central topics and issues in psychopharmacology, biological psychiatry and behavioral neurosciences, with information about developments in the field, including novel drugs and technologies. The more than 2000 entries are written by leading experts in pharmacology and psychiatry and comprise in-depth essays, illustrated with full-color figures, and are presented in a lucid style.

Handbook of Cannabis and Related Pathologies

Handbook of Cannabis and Related Pathologies
  • Author : Victor R. Preedy
  • Publisher : Academic Press
  • Release : 31 December 2016
GET THIS BOOKHandbook of Cannabis and Related Pathologies

Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment is the first book to take an interdisciplinary approach to the understanding of cannabis use and misuse. Recent worldwide trends toward decriminalizing marijuana for medical use have increased legal use of the drug and recreational use remains high, making cannabis one of the most commonly used drugs. Cannabis has a wide range of adverse neurological effects, and use and abuse can lead to physical, social, and psychopathological issues that

Melatonin

Melatonin
  • Author : Cristina Manuela Drăgoi,Alina Crenguţa Nicolae
  • Publisher : BoD – Books on Demand
  • Release : 21 November 2018
GET THIS BOOKMelatonin

Melatonin, the pineal neurohormone, is a pleiotropic molecule acting in the center of the integrative molecular mechanisms of the organism, based on interconnections of the regulatory systems: neural, endocrine, immune, and genetic, conveying into the uniqueness of human architecture. This book provides a systematic and updated overview of melatonin biochemical mechanisms of action, pharmacological features, and clinical uses, clutching the subject with complete details of pharmaceutical formulations designed for different routes of administration and different health issues, aiming at optimal

Neuronal Nicotinic Receptors

Neuronal Nicotinic Receptors
  • Author : F. Clementi,D. Fornasari,C. Gotti
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOKNeuronal Nicotinic Receptors

Neuronal nicotinic receptors are key molecules for signal transduction in a number of neuronal pathways. They are widely distributed in the brain and are known to be involved in cognitive tasks, including learning and memory, in smoking addiction and in several brain diseases, such as Alzheimer's and Parkinson's dementias, schizophrenia, and epilepsy. This book provides a comprehensive review of the field, starting with a historical perspective and dealing with the molecular structure of these receptors, their biophysical and pharmacological properties,

Marijuana and the Cannabinoids

Marijuana and the Cannabinoids
  • Author : Mahmoud A. ElSohly
  • Publisher : Springer Science & Business Media
  • Release : 15 November 2007
GET THIS BOOKMarijuana and the Cannabinoids

Although primarily used today as one of the most prevalent illicit leisure drugs, the use of Cannabis sativa L., commonly referred to as marijuana, for medicinal purposes has been reported for more than 5000 years. Marijuana use has been shown to create numerous health problems, and, consequently, the expanding use beyond medical purposes into recreational use (abuse) resulted in control of the drug through international treaties. Much research has been carried out over the past few decades following the identification of